The Cyprus Institute of Neurology and Genetics has unveiled a new method for genetic testing of embryos to help families with hereditary diseases have healthy children.

The method is based on so-called preimplantation genetic diagnosis (PGT-M). In this process, embryos are genetically examined as part of artificial insemination before they are placed in the uterus. The aim is to avoid severe monogenic diseases such as beta-thalassemia, cystic fibrosis or sickle cell anemia.

According to the institute, the new long sequencing technology enables significantly faster and more precise results than previous methods. Families with complicated genetic prerequisites could benefit in particular.

At the same time, the development is also causing discussions. Critics warn that the increasing shift of human reproduction to the laboratory could shift ethical boundaries in the long term. While embryos are currently being selected, some experts and citizens fear that modern genetic engineering could also enable targeted genetic modifications in the future.

The debate ranges from medical progress and disease prevention to questions about embryo selection, "designer babies" and the growing influence of technological interventions on natural reproduction.

Currently, genetic modifications to embryos are strictly regulated or prohibited in Europe. Nevertheless, medical progress shows how quickly the possibilities of modern genetics are evolving.







Source: CyprusMail.com